Logo CICANCER

Regulatory programs associated with trastuzumab resistance in HER2-positive breast cancer

Regulatory programs associated with trastuzumab resistance in HER2-positive breast cancer

Neda Mansouri

Centro de Investigación del Cáncer (CSIC, USAL, FICUS)

Date: 03/09/2026
Time: 12:30
CIC Lecture Hall
Host: Atanasio Pandiella